Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study. (scientific article)

Effectiveness of seasonal 2008–2009, 2009–2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case–control study

Q30394200

Safety and effectiveness of a 2009 H1N1 vaccine in Beijing

Q30397415

Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.

Q30399334

Effectiveness of influenza vaccine in the community-dwelling elderly

Q34007308

Evidence of bias in estimates of influenza vaccine effectiveness in seniors

Q34478438

Assessing vaccine efficacy in the field. Further observations

Q39560755

Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks

Q50129178

Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study

Q21144621

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

Q29616833

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.

Q30227381

Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis

Q30227428

Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination.

Q30379529

Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adults.

Q30379899

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

Q30380578

Response to a monovalent 2009 influenza A (H1N1) vaccine.

Q30380581

MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database.

Q30380647

Critical care services and 2009 H1N1 influenza in Australia and New Zealand.

Q30381497

A novel influenza A (H1N1) vaccine in various age groups.

Q30381838

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

Q30383576

Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial.

Q30383579

Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial.

Q30383723

P433

issue

P407

language of work or name

English

Q1860

P304

page(s)

5919-5924

P577

publication date

2011-06-30

P1433

published in

Vaccine

Q7907941

P1476

title

Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study

P478

volume

Reverse relations

cites work (P2860)

Q47658890	AS03- and MF59-Adjuvanted Influenza Vaccines in Children
Q64245361	Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations
Q30401497	Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus
Q34805068	Effectiveness of A(H1N1)pdm09 influenza vaccine in adults recommended for annual influenza vaccination
Q30418619	Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study
Q34707079	Effectiveness of MF59™ adjuvanted influenza A(H1N1)pdm09 vaccine in risk groups in the Netherlands
Q30367263	Effectiveness of pandemic and seasonal influenza vaccines in preventing laboratory-confirmed influenza in adults: a clinical cohort study during epidemic seasons 2009-2010 and 2010-2011 in Finland.
Q30419179	Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization
Q30410814	Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice
Q30429825	Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010.
Q30377295	Enhanced Estimates of the Influenza Vaccination Effect in Preventing Mortality: A Prospective Cohort Study.
Q51174772	Estimates of influenza vaccine effectiveness in primary care in Scotland vary with clinical or laboratory endpoint and method--experience across the 2010/11 season.
Q42270731	Evaluation and sensitivity analysis of the effectiveness of unadjuvanted A(H1N1)pdm09 vaccine in hospital workers using multi-center cohort study in Korea
Q30354921	Evaluation of the Effectiveness of Pandemic Influenza A(H1N1) 2009 Vaccine Based on an Outbreak Investigation During the 2010-2011 Season in Korean Military Camps
Q30367156	Household transmission of influenza A(H1N1)pdm09 in the pandemic and post-pandemic seasons.
Q28742719	I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe
Q30413786	Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses.
Q30427501	Live attenuated seasonal and pandemic influenza vaccine in school-age children: a randomized controlled trial
Q34778408	Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review
Q30417417	Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls
Q30361429	Protective effects of influenza A (H1N1) pandemic 2009 vaccination against the onset of influenza-like illness and asthma exacerbation in Japanese children.
Q95400325	Quantifying the efficacy of influenza vaccines
Q37998104	Risk factors and effectiveness of preventive measures against influenza in the community
Q90692852	The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology
Q38803189	Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies

P356	DOI	10.1016/J.VACCINE.2011.06.063
P698	PubMed publication ID	21723358